… In conclusion, UVA-1 treatment as primary therapy for acute GVHD of the skin is feasible,
well tolerated and effective in an outpatient setting irrespective of age or type of conditioning. …

… patients treated with UVA1 as primary therapy for acute GVHD of the skin as well as the
outcome of UVA1 treatment in 10 patients with chronic GVHD treated at the University of Leipzig. …

… showed involvement of the liver and gut by acute GVHD. … Furthermore, there are few reports
of successful treatment of acute GVHD … UVA and PUVA therapy in the treatment of cutaneous …

… to treat steroid-resistant acute GVHD of the skin. The objectives of this study were (1) to assess
… ments administered was 16 (range, 1-78), with a mean cumulative UVA exposure of 41 J/…

… to further subdivide UVA into UVA 2 (far UVA, 320-340 nm) and UVA 1 (near UVA, 340-400
nm). This suggestion was based on the observation that wavelengths in the UVA 2 region …

… extracorporeal photopheresis, chronic sclerodermic GVHD of the skin is … UVA1 (340-400
nm) therapy for scleroderma,1-3 we treated 6 patients who had sclerodermic GVHD with UVA1 …

… divided into acute and chronic GVHD, both displaying a particular pattern. Acute GVHD may
… 8‐methoxypsoralen (0.6 mg kg −1 body weight) was administered 2 h before UVA exposure…

… Acute GvHD is characterized by cytolytic damage of host … Although incidence and
severity of acute GvHD can be … sandwich of clear, UVA transparent acrylic plates with a 1-mm …

… acute graft-versus~host disease across complete major histocompatibility barriers in
lethally X-irradiated mice was significantly suppressed after bone marrow transplantation with …

… Despite immunosuppressive therapy (100 mg azathioprine and 10 mg prednisolone daily),
he developed acute GVHD of the gastrointestinal tract and 10 months later chronic GVHD of …